Normally, DNA is transcribed, or copied, to RNA and then translated to protein. Reverse transcriptase copies RNA back to DNA. Think of it as a car moving down a one-way street. Normally traffic only moves in one direction. But then, someone from out of town is driving the opposite way! Reverse transcriptase drives the opposite way in molecular processes in cells, converting RNA back to DNA.
In the last several years, global market of Reverse Transcriptase developed smoothly, with an average growth rate of 4.6 %. In 2016, global revenue of Reverse Transcriptase is nearly 260 million USD: the actual production is about 570 liter.
The classification of Reverse Transcriptase includes MMLV Reverse Transcriptase and AMV Reverse Transcriptase: Moloney Murine Leukemia Virus (MMLV) Reverse Transcriptase is an RNA-directed DNA polymerase. This enzyme can synthesize a complementary DNA strand initiating from a primer using either RNA (cDNA synthesis) or single-stranded DNA as a template. And the sales proportion of MMLV Reverse Transcriptase in 2016 is about 80.9%.
Reverse Transcriptase can be used for PCR, Sequencing and Cloning, PCR was the largest application segment in 2016, and the proportion is about 59.4%. The application used in cloning with the fastest growth rate.

According to this study, over the next five years the Reverse Transcriptase market will register a 3.4% CAGR in terms of revenue, the global market size will reach US$ 330 million by 2024, from US$ 280 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Reverse Transcriptase business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Reverse Transcriptase market by product type, application, key manufacturers and key regions and countries.

This study considers the Reverse Transcriptase value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3: and forecast to 2024 in section 11.7.
MMLV Reverse Transcriptase
AMV Reverse Transcriptase
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4: and forecast to 2024 in section 11.8.
PCR
Sequencing
Cloning

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher
Promega
Roche
Bio-Rad
Takara Bio
Agilent
Qiagen
Fapon Biotech
Toyobo
Vazyme
New England Biolabs

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Reverse Transcriptase consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Reverse Transcriptase market by identifying its various subsegments.
Focuses on the key global Reverse Transcriptase manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Reverse Transcriptase with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Reverse Transcriptase submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.